| Byrnes Tatford, | |
|
2115 Dulles Dr, Lafayette, LA 70506-2652 | |
| (337) 981-9182 | |
| (337) 988-3441 |
| Full Name | Byrnes Tatford |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 9 Years |
| Location | 2115 Dulles Dr, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093191108 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 09058 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mts-lgh Therapy Services Llc | 1052683174 | 25 |
News Archive
Postoperative adhesions are a major complication in strabismus surgery. Amniotic membrane has been used in the hopes of preventing these adhesions by forming a biological barrier during healing. In an article in the December 2010 issue of the Journal of AAPOS, a team of researchers from Cairo University have discovered that the new approach may also have the opposite effect.
The National Comprehensive Cancer Network Oncology Research Program has been awarded a $2.2-million grant from Astellas Pharma, Inc. and Medivation, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of enzalutamide in solid tumors, including bladder, breast, endometrial, hepatocellular, ovarian, and prostate cancers.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a commercialization agreement with Novartis under which Prometheus acquired exclusive rights to distribute, promote and sell PROLEUKIN® (aldesleukin) in the United States.
Clinical trials using patients' own immune cells to target tumors have yielded promising results. However, this approach usually works only if the patients also receive large doses of drugs designed to help immune cells multiply rapidly, and those drugs have life-threatening side effects. Now a team of MIT engineers has devised a way to deliver the necessary drugs by smuggling them on the backs of the cells sent in to fight the tumor. That way, the drugs reach only their intended targets, greatly reducing the risk to the patient.
› Verified 6 days ago
| Provider Name | Mts-lgh Therapy Services Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1972024081 PECOS PAC ID: 1052683174 Enrollment ID: O20170823003325 |
News Archive
Postoperative adhesions are a major complication in strabismus surgery. Amniotic membrane has been used in the hopes of preventing these adhesions by forming a biological barrier during healing. In an article in the December 2010 issue of the Journal of AAPOS, a team of researchers from Cairo University have discovered that the new approach may also have the opposite effect.
The National Comprehensive Cancer Network Oncology Research Program has been awarded a $2.2-million grant from Astellas Pharma, Inc. and Medivation, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of enzalutamide in solid tumors, including bladder, breast, endometrial, hepatocellular, ovarian, and prostate cancers.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a commercialization agreement with Novartis under which Prometheus acquired exclusive rights to distribute, promote and sell PROLEUKIN® (aldesleukin) in the United States.
Clinical trials using patients' own immune cells to target tumors have yielded promising results. However, this approach usually works only if the patients also receive large doses of drugs designed to help immune cells multiply rapidly, and those drugs have life-threatening side effects. Now a team of MIT engineers has devised a way to deliver the necessary drugs by smuggling them on the backs of the cells sent in to fight the tumor. That way, the drugs reach only their intended targets, greatly reducing the risk to the patient.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Byrnes Tatford, 2115 Dulles Dr, Lafayette, LA 70506-2652 Ph: (337) 981-9182 | Byrnes Tatford, 2115 Dulles Dr, Lafayette, LA 70506-2652 Ph: (337) 981-9182 |
News Archive
Postoperative adhesions are a major complication in strabismus surgery. Amniotic membrane has been used in the hopes of preventing these adhesions by forming a biological barrier during healing. In an article in the December 2010 issue of the Journal of AAPOS, a team of researchers from Cairo University have discovered that the new approach may also have the opposite effect.
The National Comprehensive Cancer Network Oncology Research Program has been awarded a $2.2-million grant from Astellas Pharma, Inc. and Medivation, Inc. to develop a program to scientifically evaluate and define the clinical effectiveness of enzalutamide in solid tumors, including bladder, breast, endometrial, hepatocellular, ovarian, and prostate cancers.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a commercialization agreement with Novartis under which Prometheus acquired exclusive rights to distribute, promote and sell PROLEUKIN® (aldesleukin) in the United States.
Clinical trials using patients' own immune cells to target tumors have yielded promising results. However, this approach usually works only if the patients also receive large doses of drugs designed to help immune cells multiply rapidly, and those drugs have life-threatening side effects. Now a team of MIT engineers has devised a way to deliver the necessary drugs by smuggling them on the backs of the cells sent in to fight the tumor. That way, the drugs reach only their intended targets, greatly reducing the risk to the patient.
› Verified 6 days ago
Christopher Davis Pt Services Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1206 E Broussard Rd Ste 100, Lafayette, LA 70508 Phone: 337-450-9111 Fax: 337-484-3164 | |
Ms. Alexandra Florian, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2448 Johnston St, Lafayette, LA 70503 Phone: 337-261-5151 | |
Prof. Renee Trahan Lane, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1398 E Bayou Pkwy Apt C, Lafayette, LA 70508 Phone: 337-280-7907 Fax: 337-993-7445 | |
Celia Marie Thibodeaux, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2390 W Congress St, Lafayette, LA 70506 Phone: 337-261-6700 Fax: 337-261-6660 | |
Rehab Solutions Of Louisiana Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 353 Doucet Rd, A-2, Lafayette, LA 70503 Phone: 337-216-7758 Fax: 337-216-7787 | |
Tayler Mckay Sonnier, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 100 Leon Dr, Lafayette, LA 70503 Phone: 337-521-7830 | |
Mr. Anthony Quinn, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2448 Johnston St, Lafayette, LA 70503 Phone: 337-261-5151 |